Skip to main content


Fig. 5 | BMC Genomics

Fig. 5

From: Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series

Fig. 5

Normalized gene expression levels for each gene contained in the PAM50 assay. The log2 normalized counts for RNA-Seq are represented in the X-axis and those for NanoString nCounter® are represented in the Y-axis. The red line represents the LOWESS smoother, which uses locally weighted polynomial regression

Back to article page